Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adipocytokine signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
2 Adipocytokine signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
3 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
4 Alcoholic liver disease 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
5 Alcoholic liver disease 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
6 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
7 Aldosterone synthesis and secretion 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
8 Aldosterone synthesis and secretion 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
9 Aldosterone synthesis and secretion 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
10 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 Fludrocortisone acetate 💬 Fludrocortisone 3件:  6 , 17, 81 💬
11 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 Fludrocortisone 💬 Fludrocortisone 3件:  6 , 17, 81 💬
12 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
13 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
14 AMPK signaling pathway 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
15 AMPK signaling pathway 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
16 AMPK signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
17 AMPK signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
18 Apelin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
19 Apelin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
20 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
21 Autophagy - animal 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
22 Autophagy - animal 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
23 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
24 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
25 cAMP signaling pathway 💬
1件: CRHR1 💬 Crinecerfont 💬 Crinecerfont 1件: 81 💬
26 cAMP signaling pathway 💬
1件: CRHR1 💬 Tildacerfont 💬 Tildacerfont 1件: 81 💬
27 cAMP signaling pathway 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
28 cAMP signaling pathway 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
29 cAMP signaling pathway 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
30 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
31 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
32 Cellular senescence 💬
1件: CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
33 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
34 Chemical carcinogenesis - receptor activation 💬
1件: AR 💬 Flutamide 💬 Flutamide 2件: 57, 81 💬
35 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
36 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
37 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
38 Circadian rhythm 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
39 Circadian rhythm 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
40 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
41 Cortisol synthesis and secretion 💬
1件: CYP17A1 💬 Abiraterone acetate 💬 Abiraterone 2件: 75, 81 💬
42 Cortisol synthesis and secretion 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
43 Cortisol synthesis and secretion 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
44 Cortisol synthesis and secretion 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
45 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
46 Cushing syndrome 💬
1件: CRHR1 💬 Crinecerfont 💬 Crinecerfont 1件: 81 💬
47 Cushing syndrome 💬
1件: CRHR1 💬 Tildacerfont 💬 Tildacerfont 1件: 81 💬
48 Cushing syndrome 💬
1件: CYP17A1 💬 Abiraterone acetate 💬 Abiraterone 2件: 75, 81 💬
49 Cushing syndrome 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
50 Cushing syndrome 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
51 Cushing syndrome 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
52 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
53 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
54 Efferocytosis 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
55 Efferocytosis 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
56 Fluid shear stress and atherosclerosis 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
57 Fluid shear stress and atherosclerosis 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
58 FoxO signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
59 FoxO signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
60 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
61 Glucagon signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
62 Glucagon signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
63 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
64 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
65 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
66 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
67 Hormone signaling 💬
1件: CRHR1 💬 Crinecerfont 💬 Crinecerfont 1件: 81 💬
68 Hormone signaling 💬
1件: CRHR1 💬 Tildacerfont 💬 Tildacerfont 1件: 81 💬
69 Hormone signaling 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
70 Hormone signaling 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
71 Hormone signaling 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
72 Huntington disease 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
73 Huntington disease 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
74 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
75 Hypertrophic cardiomyopathy 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
76 Hypertrophic cardiomyopathy 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
77 Insulin resistance 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
78 Insulin resistance 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
79 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
80 Insulin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
81 Insulin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
82 Lipid and atherosclerosis 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
83 Lipid and atherosclerosis 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
84 Long-term depression 💬
1件: CRHR1 💬 Crinecerfont 💬 Crinecerfont 1件: 81 💬
85 Long-term depression 💬
1件: CRHR1 💬 Tildacerfont 💬 Tildacerfont 1件: 81 💬
86 Long-term potentiation 💬
1件: CACNA1C 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
87 Longevity regulating pathway 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
88 Longevity regulating pathway 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
89 Longevity regulating pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
90 Longevity regulating pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
91 Longevity regulating pathway - multiple species 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
92 Longevity regulating pathway - multiple species 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
93 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
94 mTOR signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
95 mTOR signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
96 Neuroactive ligand-receptor interaction 💬
1件: CRHR1 💬 Crinecerfont 💬 Crinecerfont 1件: 81 💬
97 Neuroactive ligand-receptor interaction 💬
1件: CRHR1 💬 Tildacerfont 💬 Tildacerfont 1件: 81 💬
98 Neuroactive ligand-receptor interaction 💬
1件: MC2R 💬 Atumelnant 💬 Atumelnant 2件: 75, 81 💬
99 Neuroactive ligand-receptor interaction 💬
1件: MC2R 💬 Corticotropin 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
100 Neuroactive ligand-receptor interaction 💬
1件: MC2R 💬 Corticotropin, repository 💬 Corticotropin 10件:  2 , 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
101 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Cortisone 💬 Cortisone 1件: 81 💬
102 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Cortisone acetate 💬 Cortisone acetate 1件: 81 💬
103 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone 💬 Dexamethasone 29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
104 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone sodium phosphate 💬 Dexamethasone 29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
105 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone phosphate 💬 Dexamethasone 29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
106 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone 💬 Hydrocortisone 10件:  6 , 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
107 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone sodium phosphate 💬 Hydrocortisone phosphate 3件: 53, 81, 83 💬
108 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone sodium succinate 💬 Hydrocortisone succinate 3件: 81, 83, 97 💬
109 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Hydrocortisone succinate 💬 Hydrocortisone succinate 3件: 81, 83, 97 💬
110 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisolone 💬 Prednisolone 48件:  3 , 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
111 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisone 💬 Prednisone 58件:  2 , 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
112 Non-alcoholic fatty liver disease 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
113 Non-alcoholic fatty liver disease 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
114 Non-alcoholic fatty liver disease 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
115 Non-alcoholic fatty liver disease 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
116 Oocyte meiosis 💬
1件: AR 💬 Flutamide 💬 Flutamide 2件: 57, 81 💬
117 Osteoclast differentiation 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
118 Osteoclast differentiation 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
119 Ovarian steroidogenesis 💬
1件: CYP17A1 💬 Abiraterone acetate 💬 Abiraterone 2件: 75, 81 💬
120 Ovarian steroidogenesis 💬
1件: CYP19A1 💬 Letrozole 💬 Letrozole 2件: 81, 89 💬
121 Ovarian steroidogenesis 💬
1件: CYP19A1 💬 Testolactone 💬 Testolactone 1件: 81 💬
122 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
123 Oxytocin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
124 Oxytocin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
125 Pathways in cancer 💬
1件: AR 💬 Flutamide 💬 Flutamide 2件: 57, 81 💬
126 Pathways in cancer 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
127 Pathways in cancer 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
128 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
129 PI3K-Akt signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
130 PI3K-Akt signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
131 PPAR signaling pathway 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
132 PPAR signaling pathway 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
133 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
134 Prolactin signaling pathway 💬
1件: CYP17A1 💬 Abiraterone acetate 💬 Abiraterone 2件: 75, 81 💬
135 Prostate cancer 💬
1件: AR 💬 Flutamide 💬 Flutamide 2件: 57, 81 💬
136 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
137 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
138 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
139 Steroid hormone biosynthesis 💬
1件: CYP17A1 💬 Abiraterone acetate 💬 Abiraterone 2件: 75, 81 💬
140 Steroid hormone biosynthesis 💬
1件: CYP19A1 💬 Letrozole 💬 Letrozole 2件: 81, 89 💬
141 Steroid hormone biosynthesis 💬
1件: CYP19A1 💬 Testolactone 💬 Testolactone 1件: 81 💬
142 Taste transduction 💬
1件: CACNA1C 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
143 Thermogenesis 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
144 Thermogenesis 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
145 Thermogenesis 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
146 Thermogenesis 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
147 Thyroid cancer 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
148 Thyroid cancer 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
149 Tight junction 💬
1件: CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
150 Tight junction 💬
2件: PRKAA1, PRKAA2 💬 Metformin hydrochloride 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
151 Tight junction 💬
2件: PRKAA1, PRKAA2 💬 Metformin 💬 Metformin 31件:  2 ,  6 ,  8 , 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
152 Transcriptional misregulation in cancer 💬
1件: PPARG 💬 Pioglitazone hydrochloride 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
153 Transcriptional misregulation in cancer 💬
1件: PPARG 💬 Pioglitazone 💬 Pioglitazone 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
154 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬
155 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 Nifedipine 💬 Nifedipine 2件: 50, 81 💬